建滔集团发盈喜 预计2025年纯利超过43.2亿港元同比上升超过165%

Core Viewpoint - Kintor Pharmaceutical (00148) expects a significant increase in net profit for the year ending December 31, 2025, projecting an increase of over 165% compared to the same period in 2024, with net profit exceeding HKD 4.32 billion [2][5] Financial Performance - The anticipated substantial rise in net profit is primarily attributed to growth in the reported segment profits from the investment business and the copper-clad laminate segment [2][5] - The demand for copper-clad laminates and its upstream materials, including fiberglass yarn, fiberglass cloth, and copper foil, remains strong, leading to a general increase in product prices and sales volume compared to 2024 [2][5]